Lexicon Pharmaceuticals | LXRX - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Abbott 23.85 1.08 2026-06
Acadia Pharmaceuticals 11.33 1.25 2026-06
Agios Pharmaceuticals 3.56 0 2026-03
Akebia Therapeutics 1.63K 1.6K 2025-12
Alnylam Pharmaceuticals 75.64 4.4 2026-06
AstraZeneca 25.34 4.25 2026-06
BioMarin Pharmaceutical 21.07 5.79 2026-06
Eli Lilly 32.9 7.37 2026-06
Halozyme Therapeutics 12.51 1.15 2026-06
Illumina 48.98 16.53 2026-06
Ironwood Pharmaceuticals 204.24 88.19 2024-12
J&J 29.43 4.9 2026-06
Lexicon Pharmaceuticals 12.44 4.73 2021-06
MannKind 201.15 102.55 2026-03
Merck 32.26 15.74 2026-06
Moderna 27.22 14.51 2023-06
Novartis 22.41 2.24 2026-06
PTC Therapeutics 8.76 1.22 2026-03
Puma Biotechnology 13.93 44.88 2024-06
Sarepta Therapeutics 27.27 0 2026-03
Thermo Fisher Scientific 26.4 1.31 2026-06
United Therapeutics 19.15 1.27 2026-06
Vanda Pharmaceuticals 16.79 7.07 2023-06